T
E

Dr. Ferrari serves as President and CEO of Houston Methodist Research Institute, where he holds the Ernest Cockrell Jr. Presidential Distinguished Chair. He is also the director of the Institute of Academic Medicine and executive vice president of Houston Methodist, and is president of The Alliance for NanoHealth in Houston. Dr. Ferrari is an academic-entrepreneur, with several companies that originated from his laboratory. He currently serves on the Board of Directors for two companies: Nanomedical Systems of Austin TX and NASDAQ-traded Arrowhead Research Corporation (NASDAQ:ARWR). He is also a director, co-founder and scientific advisor for Leonardo Biosystems of Houston TX. Dr. Ferrari served as special expert on nanotechnology at the National Cancer Institute in 2003-2005, providing leadership into the formulation, refinement, and approval of the NCI’s Alliance for Nanotechnology in Cancer, currently the world’s largest program in medical nanotechnology. Dr. Mauro Ferrari is a founder of biomedical nano/micro-technology, especially in their applications to drug delivery, cell transplantation, implantable bioreactors, and other innovative therapeutic modalities. In these fields, he has published more than 200 peer-reviewed journal articles and six books. He is the inventor of more than 30 issued patents, with about thirty more pending in the US and internationally.